title: The metabolic syndrome: definition, diagnosis and management.
authors.forename: S
authors.initials: S
authors.lastname: Novo
authors.forename: A
authors.initials: A
authors.lastname: Balbarini
authors.forename: J J
authors.initials: JJ
authors.lastname: Belch
authors.forename: F
authors.initials: F
authors.lastname: Bonura
authors.forename: D L
authors.initials: DL
authors.lastname: Clement
authors.forename: E
authors.initials: E
authors.lastname: Diamantopoulos
authors.forename: J
authors.initials: J
authors.lastname: Fareed
authors.forename: L
authors.initials: L
authors.lastname: Norgren
authors.forename: P
authors.initials: P
authors.lastname: Poredos
authors.forename: K
authors.initials: K
authors.lastname: Rotzocil
mesh_terms: D019440:Anti-Obesity Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D004435:Eating; D015444:Exercise; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008019:Life Style; D024821:Metabolic Syndrome / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D009626:Terminology as Topic; D016896:Treatment Outcome
chemical_list: D019440:Anti-Obesity Agents; D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents